Antibiotic-resistant bacteria cost hundreds of thousands of lives. The development of new active substances is faltering. New initiatives, including those from Luxembourg, want to tackle the problem.

Check out the article, published on August 4 in Wort, with the interview of Dr Alexandre Mzabi, deputy head of the bacteriology, mycology, antibiotic resistance and hospital hygiene service of the microbiology deparement at LNS.